Replies to post #330408 on Avid Bioservices Inc (CDMO)

[biopharm]

Are you positive?

Try asking Susan MacIntyre whom left Beyond Springs for Oncologie and she sees the benefit of PS Targeting that EVERY IO player will require to adjust that M1/M2 macrophage ratio back to M1

https://www.globenewswire.com/news-release/2019/03/26/1767477/0/en/BeyondSpring-s-Lead-Asset-Plinabulin-Shifts-the-Balance-of-Macrophages-Towards-Anti-Cancer-M1s.html

You may also want to ask the phase 3 Sunrise patients that had Bavituxab before going to Keytruda

Why has not the FDA released that data to the public yet? Some don't want some to find out

Spring time, back to mowing lawns